Aptus Pharma Announcements
Intimation pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 regarding Press release - Aptus Pharma expands OTC presence in Gujarat, Strengthens Cosmeceutical Portfolio
12 Dec, 2025 | 02:21pm • Source: BSE
Regulation 30 Disclosure - Entry into the Urology Therapy Segment
21 Nov, 2025 | 07:20pm • Source: BSE
Submission of Monitoring Agency report for the period ended 30th September. 2025.
12 Nov, 2025 | 06:16pm • Source: BSE
Intimation of new product- ENZYKING SYRUP
12 Nov, 2025 | 06:08pm • Source: BSE
Intimation of new product- SHIROVITA HAIR OIL (AYURVEDIC HAIR OIL)
12 Nov, 2025 | 06:06pm • Source: BSE
Unaudited Financial Results for the Half Year Ended on 30th September, 2025
11 Nov, 2025 | 06:58pm • Source: BSE
Unaudited Financial Results for the half year ended on 30th September, 2025
10 Nov, 2025 | 07:00pm • Source: BSE
Board Meeting Outcome for Approval Of Unaudited Financial Results For The Half Year Ended on 30th September, 2025
10 Nov, 2025 | 06:53pm • Source: BSE
Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and...
01 Nov, 2025 | 09:11pm • Source: BSE
take on record clarification for price movement
21 Oct, 2025 | 04:20pm • Source: BSE
The Exchange has sought clarification from Aptus Pharma Ltd on October 17, 2025, with reference to significant movement in price, in order to ensure that...
17 Oct, 2025 | 06:57pm • Source: BSE
Compliance certificate under regulation 74(5) of SEBI ((DP) Regulation, 2018 for half year ended as on 30th September, 2025
14 Oct, 2025 | 11:55pm • Source: BSE
PLEASE TAKE ON RECORD CLOSURE OF TRADING WINDOW DUE TO SUBMISSION OF HALF YEARLY UNAUDITED FINANCIAL STATEMENT
01 Oct, 2025 | 05:59pm • Source: BSE
Trading Members of the Exchange are hereby informed that effective from September 30, 2025, the equity shares of Aptus Pharma Ltd (Scrip Code: 544529) are...
30 Sep, 2025 | 08:07am • Source: BSE